AKZO NOBEL NV

AKZO NOBEL NV operates as a diversified, global company with activities in human and animal healthcare, coatings, and chemicals. The company's operations are organized into segments based on the affinity between activities. These segments include Human Pharmaceuticals (Organon) and Animal Health (Intervet), which are collectively referred to as Pharma, and Coatings and Chemicals. Within the Coatings and Chemicals segment, activities are conducted through various business units. The Board of Management is responsible for defining the strategic direction, establishing policies, and managing the company's daily operations. Key corporate tasks are coordinated across areas such as strategy, finance, control, human resources, technology, legal affairs and intellectual property, communications, health, safety, and environment, information management, and risk and insurance management. AKZO NOBEL NV's strategy focuses on creating above-average economic value over the business cycle. The company aims to build sustainable leading business positions, characterized by attractive growth, returns significantly above the costs of capital, and substantial operational cash flows. It actively restructures and divests activities that do not meet its criteria. The company develops competitive advantages by combining a customer focus and entrepreneurial spirit from its decentralized business unit organization with the scale of a global organization, which provides access to global capital markets, managerial talent, best management practices, and purchasing power.